Syringe and a box of Johnson & Johnson vaccine.
Paul Hennessy | SOPA images | LightRocket | beautiful pictures
Only Johnson & Johnson the facility that is currently producing batches of the company’s usable single-shot coronavirus vaccine has suspended production, a new report said on Tuesday.
The Dutch-based factory has instead focused on creating a different, possibly more beneficial vaccine that targets a different virus, The New York Times reported, citing people familiar with the matter.
The production halt at the Leiden facility, which began late last year and is expected to last several months, could reduce the supply of J&J’s Covid vaccine by hundreds of millions of doses, one of the people told the Times.
It remains unclear whether vaccine supplies will be affected by the company’s move, according to the report. J&J is preparing for the Leiden factory to restart production of the Covid vaccine in March, the Times reported.
J&J spokesman Jake Sargent did not directly comment on the Times article. He told CNBC in a statement that the company is “focused on making sure our vaccines are available where people need them” and that it is fulfilling its obligations to groups. International is trying to increase access to a Covid vaccine.
J&J is continuing to deliver batches of vaccine ingredients to dosing and packing sites, and “we currently have millions of doses of Covid-19 vaccine in stock,” Sargent said.
“We are proud of the work of many of our industry partners and the collaboration we have developed to produce a COVID-19 vaccine,” he said.
Opinion poll that many Americans have had a skeptical eye for the J&J Covid vaccine, the only one approved The U.S. Food and Drug Administration requires only a single injection as the main dose, compared with a two-dose regimen of vaccines produced by Pfizer and Moderna.
FDA last year It is recommended to suspend the use of J&J . vaccine after a small number of reports of recipients developing rare blood clots. It was also found to be less effective against deadly delta variant appeared last year.
But some studies have shown that Still effective in preventing hospitalizations and deaths from Covidand a The booster dose has been shown to be effective in protecting against severe disease caused by the highly infectious omicron variant.
The J&J vaccine is also easier to transport and distribute, as it requires only one dose and can be stored without the need for a freezer, helping to increase accessibility to those who may not be fully vaccinated.
